Form 4: Agilon Health Director Diana McKenzie Reports Acquisition of 32,119 Shares of Common Stock

Director Diana McKenzie reported acquiring 32,119 shares of Agilon Health common stock on May 29, 2024, and now beneficially owns 38,819 shares.

Summary

• On May 29, 2024, Diana McKenzie, a director of Agilon Health, Inc. (AGL), acquired 32,119 shares of common stock.
• The acquisition was in the form of restricted stock units that vest in full on May 29, 2025, contingent upon continued service as a director.
• The price per share for the acquisition was $0.
• Following the transaction, McKenzie beneficially owns a total of 38,819 shares, including restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a standard insider transaction, with the director increasing their stake in the company, which is generally viewed as a positive sign, but it's not overwhelmingly significant.

Positives

• The acquisition of shares by a director signals confidence in the company's future.

Future Outlook

The restricted stock units vest in full on May 29, 2025, subject to continued service as a director.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment, as it indicates confidence from a member of the board of directors.

Key Dates